|
業務類別
|
Biotechnology |
|
業務概覽
|
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product. |
| 公司地址
| 110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920 |
| 電話號碼
| +1 908 842-0100 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.lisata.com |
| 員工數量
| 26 |
| Mr. Tariq Imam |
Senior Vice President, Business Development and Operations and General Counsel |
-- |
25/04/2025 |
| Ms. Kristen K. Buck |
Executive Vice President, Research and Development and Chief Medical Officer |
美元 597.42K |
25/04/2025 |
| Dr. David J. Mazzo, PhD |
President, Chief Executive Officer and Director |
美元 702.97K |
25/04/2025 |
| Mr. James Nisco |
Senior Vice President, Finance and Treasury, Principal Financial Officer and Chief Accounting Officer |
美元 341.94K |
25/04/2025 |
|
|
| Ms. Cynthia L. Flowers |
Independent Director |
25/04/2025 |
| Ms. Heidi Henson, C.P.A. |
Independent Director |
25/04/2025 |
| Mr. Steven M. Klosk |
Independent Director |
25/04/2025 |
| Dr. Gregory B. Brown,M.D. |
Chairman of the Board |
25/04/2025 |
| Dr. Mohammad Azab, M.B.A.,M.D.,M.Sc. |
Independent Director |
25/04/2025 |
| Dr. David J. Mazzo, PhD |
President, Chief Executive Officer and Director |
25/04/2025 |
|
|
|
|
